findmyKOL

Jonathan Waltuck, MD

Basic profile

Emory University

ORCIDNone on fileNPI
RegionAtlanta, GA · SoutheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 1999findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1998–1999Why? →

Jonathan Waltuck is a Rheumatology/Immunology physician affiliated with Emory University. OpenAlex indexes 10 publications with 572 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
10publications

Distinct works indexed by OpenAlex.

572citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1998–1999

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    28.6%
    Opioid Agonist16.6%
    Tramadol Hcl32%Oxycodone-Acetaminophen24%Oxycodone Hcl18%Morphine Sulfate Er13%Fentanyl6%Oxycontin5%Tramadol Hcl Er2%
    Part D<11 patients
    Benzodiazepine3.7%
    Alprazolam61%Clonazepam19%Lorazepam12%Temazepam9%
    Part D<11 patients

    + 6 more classes in this area

  • Cancer & immunology

    21.8%
    TNF inhibitor8.7%
    Enbrel Sureclick34%Humira Pen19%Humira(Cf) Pen14%Enbrel11%Humira9%Humira(Cf)7%Cimzia7%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor6.6%
    Methotrexate100%
    Part D72 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    20.4%
    Corticosteroid15.3%
    Prednisone100%
    Part D167 patients
    Proton pump inhibitor2.1%
    Omeprazole33%Pantoprazole Sodium31%Esomeprazole Magnesium24%Dexlansoprazole Dr13%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19981999 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”